Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/Ib Study of Nivolumab in Combination With Therasphere (Yttrium-90) in Patients With Advanced Hepatocellular Carcinoma

NCT02837029 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02837029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02837029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/Ib Study of Nivolumab in Combination With Therasphere (Yttrium-90) in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2016
Completion date
November 1, 2020
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iiia hepatocellular carcinoma, stage iiib hepatocellular carcinoma, stage iiic hepatocellular carcinoma, stage iva hepatocellular carcinoma, stage ivb hepatocellular carcinoma